Recovery of visual function after removal of chronic subfoveal perfluorocarbon liquid.

These symptoms can include weakness, fatigue, spontaneous bleeding, and increased infection.3 As the disease progresses, hypercalcemia due to increased bone resorption is often seen.3 Commonly, patients can develop kidney involvement, resulting in renal failure.3 In this case, the patient had none of these signs and symptoms when she initially presented with visual complaints. In the literature, there is a report of known systemic multiple myeloma with choroidal involvement,1 and there is a case of an extramedullary plasmacytoma in the choroid without development of multiple myeloma.2 This case demonstrates that systemic multiple myeloma can present initially as an amelanotic choroidal mass that simulates a choroidal melanoma. The diagnosis of choroidal plasmacytoma in this case is strongly supported by the rapid and complete response of the lesion to radiotherapy. In addition, the finding of multiple systemic plasmacytomas further supports the diagnosis. References 1. Sandberg HO, Westby RK, Arnesen K. Plasmacytoma of the uvea in a case of multiple myeloma. Acta Ophthalmol 1989; 67:329–332. 2. Honavar SG, Shields CL, Shields JA, Demirci H, Ehya H. Extramedullary plasmacytoma confined to the choroid. Am J Ophthalmol 2001;131:277–278. 3. Munshi NC, Tricot G, Barlogie B. Plasma cell neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th ed. Vol 2. Philadelphia: Lippincott Williams & Wilkins, 2001:2465–2491.